Revisiting neoadjuvant therapy in non-small-cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Revisiting neoadjuvant therapy in non-small-cell lung cancer

Published:2021-11 Issue:11 Volume:22 Page:e501-e516
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Saw Stephanie P L,Ong Boon-Hean,Chua Kevin L M,Takano Angela,Tan Daniel S W

Funder

Merck

Roche

Takeda Pharmaceutical Company

National Medical Research Council

GlaxoSmithKline

Publisher

Elsevier BV

Subject

Oncology

Reference82 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. The effect of advances in lung-cancer treatment on population mortality;Howlader;N Engl J Med,2020

3. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group;Pignon;J Clin Oncol,2008

4. Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non–small-cell lung cancer;Felip;J Clin Oncol,2010

5. Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non–small-cell lung cancer;Scagliotti;J Clin Oncol,2011

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single‐cell RNA sequencing reveals microenvironmental infiltration in non‐small cell lung cancer with different responses to immunotherapy;The Journal of Gene Medicine;2024-09

2. Multiporous PMMA microballs as a novel fluorescence tissue marker;Chemical Engineering Journal;2024-09

3. Conséquences chirurgicales et anatomopathologiques de l’immunothérapie préopératoire en onco-urologie;Bulletin du Cancer;2024-09

4. Two-polarized roles of transcription factor FOSB in lung cancer progression and prognosis: dependent on p53 status;Journal of Experimental & Clinical Cancer Research;2024-08-21

5. Assessment of the Pathologic Response to Neoadjuvant Therapy;Haigan;2024-08-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3